The Advisory Committee on Immunization Practices’ Recommendation for Use of Moderna COVID-19 Vaccine in Adults Aged ≥18 Years and Considerations for Extended Intervals for Administration of Primary Series Doses of mRNA COVID-19 Vaccines — United States, February 2022
Megan Wallace(Centers for Disease Control and Prevention), Sara E. Oliver(Centers for Disease Control and Prevention), John R. Su(National Center for Emerging and Zoonotic Infectious Diseases), Danielle Moulia(Centers for Disease Control and Prevention), Oliver Brooks, Ruth Link‐Gelles(Centers for Disease Control and Prevention), Faisal S. Minhaj(The Centers), a cura di Luciano De Fiore, Sarah Meyer, Erin K. Ricketts(Alabama Department of Public Health), Stephen C. Hadler(The Task Force for Global Health), Tom T. Shimabukuro(Centers for Disease Control and Prevention), Matthew F. Daley(Kaiser Permanente), Monica Godfrey, Grace M. Lee, Kathryn Curran(World Health Organization), Matthew E. Oster(Children's Healthcare of Atlanta), Amy Blain, H. Keipp Talbot(Marshfield Clinic), Rebecca L. Morgan(Impact), Amimah Asif, Beth P. Bell(Centers for Disease Control and Prevention), Eric Weintraub, Elisha Hall, Doug Campos‐Outcalt
Cited by 43
Related Papers
Multisystem Inflammatory Syndrome in U.S. Children and Adolescents
|New England Journal of Medicine|2020|2.7k
Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (April 2020)
|Clinical Infectious Diseases|2020|1.1k
Effects of the COVID-19 Pandemic on Routine Pediatric Vaccine Ordering and Administration — United States, 2020
|MMWR Morbidity and Mortality Weekly Report|2020|720
Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US From December 2020 to August 2021
|JAMA|2022|670
Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices — United States, June 2021
|MMWR Morbidity and Mortality Weekly Report|2021|602